Psykey, Inc. (OTCMKTS:CEOS) Short Interest Update

Psykey, Inc. (OTCMKTS:CEOS) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totalling 6,100 shares, an increase of 154.2% from the December 31st total of 2,400 shares. Based on an average daily volume of 2,092,600 shares, the short-interest ratio is presently 0.0 days.

Psykey Stock Performance

CEOS traded down $0.00 during midday trading on Friday, hitting $0.02. 334,873 shares of the company traded hands, compared to its average volume of 1,147,083. The business has a 50 day simple moving average of $0.03 and a two-hundred day simple moving average of $0.03. Psykey has a 52-week low of $0.01 and a 52-week high of $0.04.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.